MK‐2206 significantly inhibited proliferation in ARNT2‐silenced NPC cells based on cell viability (Figure 6G and H), migration and invasion ability (Figure 6I and J). This evidence concerns the gene ARNT2 and nasopharyngeal carcinoma.